Member Info for Tiger16

Morri 940 .. many thanks .. Your a angle with wings .. so lets keep flying today ..

and for those jealous posts against me , I have been in and out of this for 9 months .. check my history , cant blame me with our CEO , now hats off he has pulled the rabbit out of the hat ..

cheers to a transformational year ..

I’ve been locked in for nine months, digging through the drill data, resource reports, and strategic positioning. I held firm—even when ROCK dropped and I was sitting 50% underwater—because this isn’t your average junior explorer.

And now? We’re seeing the re-rating happen.

Here’s why it makes total sense:

⸻

Why ROCKFIRE is getting its day—and soon

1. Molaoi: one of Europe’s most valuable undeveloped zinc deposits

The Molaoi project in Greece now boasts 15 million tonnes at ~9.96 % ZnEq (zinc equivalent), with 1.09 million tonnes of zinc, 260,000 t lead, and 19.1 million oz silver in inferred resources  . That alone lands Molaoi among the top 20 undeveloped zinc deposits globally .

2. High-value by-products: Germanium (and Gallium)

Rockfire’s Molaoi holds roughly 105,000 kg of germanium, a critical mineral Europe desperately needs  . Germanium (and gallium) are on both EU and US critical minerals lists—and China has restricted exports  . That adds serious upside to economics.

3. Europe needs these minerals—deep pocket interest follows

The EU plans to direct over €10 billion toward exploration and securing critical minerals, part of a broader push to build autonomy away from third-party supply chains . ROCK is sitting squarely in that spotlight as a European-sourced critical supply.

4. Re-rating reflects recognition of strategic value

Insiders and observers are waking up. A social media post I saw put it succinctly:

“Mc ap £4.5 m with $6 Billion resource value”—and they’re not wrong .

That kind of potential puts the company firmly back on the map.

⸻

So, why I didn’t flinch—and why you shouldn’t either

I’ve sat through the drop because I knew I was buying into real, tangible assets—not hype. I knew Europe would need these resources badly, and sooner rather than later. Now, with drilling ramping up again  and research reinforcing Molaoi’s strategic cache , re-rating is inevitable.

Bottom line: billions are at stake, and a buyout is increasingly likely

Make no mistake—the critical minerals at Molaoi aren’t just valuable; they’re strategically priceless to Europe. When big players eye domestic supply, ROCK becomes a prime candidate for a fast—and lucrative—acquisition.

Honestly, I thought I’d missed the boat yesterday when I saw prices climbing—but then a kind soul on here told me, “Tiger, you haven’t.” That tipped the scale, so I jumped back in at 7.70p. Couldn’t be happier.

But seriously—if you can, get in before 10p. This is gearing up to run hard, and it’s not just hype.

Their late-stage asset, P140, is a game-changer. It’s a first-in-class “Immunormalizer” that doesn’t suppress your immune system—it restores immune balance instead  . They’ve identified a new subgroup, Type M super-responders, and have filed a patent that could grant them 20 years of commercial exclusivity for both the drug and its companion diagnostic test  .

This isn’t just a lupus play anymore—it’s potentially applicable across up to 50 autoimmune diseases. The total addressable therapeutic market is over $100 billion a year, plus another $10 billion diagnostics market    .

Let’s talk valuation—not speculation, but grounded in precedent. One investor noted that similar platform-style or immune/autoimmune deals have fetched $4–7 billion: e.g. Gilead–Forty Seven ($4.9B), Pfizer–Arena ($6.7B), Sanofi–Principia (~$3.7B) . Add a big premium for pairing therapy with diagnostics—it moves ImmuPharma from a single-asset biotech to a precision-medicine platform with massive value potential.

Realistically? A buyout in the range of $3.5–6 billion isn’t out of the question .

So yeah—this late-stage asset is worth many billions, and a buyout isn’t unlikely anymore—it’s just a matter of when.

Or cebo is it that the assay results are not commercial viable and they are seeking desperately to get some holes to show some positivity . That the risk here . I’m holding .. it’s worth the chance .. let’s see

There will be no re trace tomorrow , as if that was the case , we would of dropped back at close .. its all about maths and calculations .

We will see a some profit taking at 10 p .. If a RNS drops tomorrow which is ambitious , yet I just fee this rise has not come out of the thin air .. it never does .. and never will ..

No I am not blasting about inside trading .. I said those in the game will get a head up. and I bought at 7 . 70 p not 1,5 p .. please get your facts right ..

Cebo 456 , Firstly I have not used Chat G.. AI , also I am not questioning your post , hence lets wait and see < I personally dont see any news here for two weeks .. These projects take time .. I hope I am wrong and we get news now .. would be great , was just high lighting that all invested here to expect up and downs until news .. I wont be selling .. no way ..

Tiger in the house , No have not sold WSBN .. its needs a couple of weeks for results .. fresh cash in here .. strong close above 8 p .. on the cards here ..

NT to buy Barclays .. yes he rumor on the drilling started last week I believe is true . hence insiders taking positions big time .. it was always a matter of time here ,, the facts speak for themselves ..

Every sell met with a huge buy check level 2 .. I expect a bumper of a RNS tomorrow .. there is no way on earth this was not insiders taking a position ..

Expect 0.30 coming in before close .. well done holders , this is just the start of our journey , just watch this unfold .. in real time ..

So basically who ever posted on this board we will have results this week , and I am guilty of also thinking we will have results RNS today / mid week , was WISHFUL THINKING .. hence most in the know smart cash wont arrive here to take positions until at least 23 rd Sept - 6 th Oct ..

So expect is to float around in this range until then , we may even slip further down or get a false spike ..

I may be wrong so please dyor which if one looks back previously on the previous assay results for WSBN , then you will may come to the same conclusion ..

Expect the first batch of assay results from the samples sent after the 18 Aug 2025 breccia intercept sometime between late-September and mid-October 2025.

Why: Wishbone (and Australian labs) typically quote ~4–6 weeks, but Wishbone’s own past announcements show actual publication often taking ~6–8 weeks. 

⸻

Evidence & precedent (most important items)

1. Current RNS (18 Aug 2025) — Wishbone said the breccia core “will now be transported to Perth to be cut and assayed” (so sample dispatch was prioritised on/after 18 Aug). That’s the start date you gave. 

2. Company wording in previous campaigns — on 12 Oct 2023 Wishbone said samples were “now en route to Intertek’s laboratories, with assay results expected in the next 4–6 weeks.” That’s the company setting an expectation window. 

3. What actually happened in 2023 — the follow-up RNS with the drill results / modelling and assays was published 4 Dec 2023, ~7½ weeks after the 12 Oct “samples en route” statement — i.e. a real-world turnaround of ~7–8 weeks for that programme. 

4. Earlier (maiden) assays — Wishbone’s maiden programme assays (positive results) were publicly reported on 13 Dec 2022, after drilling through 2022 — shows they do report staged assay batches rather than everything instantly. (This illustrates that timings can stretch while the company batches results). 

5. Industry / lab reality — major Australian assay labs (Intertek, ALS, SGS etc.) routinely handle exploratory workflows where fire-assay and multi-element packages are measured; industry commentary and lab service pages show that fire-assay workflows commonly take days → several weeks, with typical exploration timelines of ~4–7 weeks from dispatch to report (and urgent/priority jobs can be faster). PhotonAssay technology can be much faster, but it’s not the default for most junior programmes.   

⸻

Practical expected dates (based on above)

• Earliest reasonable / optimistic: ~5 weeks after 18 Aug → 23–25 Sep 2025. (If Wishbone fast-tracked core & labs prioritised.) 

• Most realistic / historically consistent: 6–8 weeks → 30 Sep – 13 Oct 2025. (Matches Wishbone’s Oct 2023 → Dec 2023 pattern.) 

• If there are busy-season delays / additional analyses: could slip to mid-October 2025 or later. 

⸻

Why it sometimes takes longer than the company’s “4–6 weeks” estimate

• labs get busy (exploration season surges);

• the company may wait to compile multiple holes and QA/QC before releasing a single RNS;

• extra confirmatory tests (4-acid dig, OES finish, repeat assays) add time;

• shipping from a remote site and core cutting logistics can introduce delays.  

Typical Assay Turnaround Timeline (Field to Results)

1. General Industry Average: 5–7 weeks

• A widely respected field geologist (Angry Geologist) summarized average assay turnarounds across regions: Peru ~28 days, Chile ~31 days, Mexico ~25 days—from sample dispatch to analysis and result delivery. Taking logistics and report prep into account, he considers 5–7 weeks a practical upper limit before results are typically announced. 

2. “Roughly Six Weeks” Standard

• Another source emphasizes that from drilling completion to public release usually spans about six weeks, though that excludes additional delays for report coordination. 

3. Australian Lab Capabilities:

• North Australian Laboratories (fire assay): can deliver results within 24 hours of receiving the sample—although this presumes prompt logistics and turnaround. 

• PhotonAssay technology (cutting-edge, CSIRO-developed):

• Produces results in as little as 2 minutes per sample—though this is more likely used in certain processing or resource definition contexts rather than bulk exploratory assays.   

4. Real-World Delays Documented in Australia

• A gold explorer (LCL Resources) noted that multi-element assay pulps shipped to Townsville sometimes take as long as eight weeks for results, especially during busy periods or with complex assays.

Expected window for results:

• Typical scenario: 5–7 weeks. That suggests a likely timeframe of late September to early October 2025.

• Possible extended delay: If complex assays or lab congestion occurred, results may come by early to mid-October (i.e., the full 8-week duration).

• Unlikely: Results by early September.

• Rapid exceptions: If WSBN used PhotonAssay or a fast-track lab (rare for juniors), results could arrive within days—but these are exceptional and generally not typical for AIM-listed explorers.

Hence has they used this process we would have had results 3 weeks ago.. so we still have some time to wait and this is why this may dip , keep holding .. it’s just a mater of a couple of weeks more ..

Anyone with years of trading experience knows this is a leak .. a spike would of ended at 30 per cent max .. You do not want to sell a beam now .. I have seen these rises before and the a RNS drops ..

86kb , I have decided to play it safe .. time to hold now .. I know this is a leak .. has to be .. just think when the news lands .. omg .. will be locked out big time , it will open 100 per cent up or be suspended .. in a good way ..

Come on guys who thinks this is a leak .,,, its was dead after the rise last week .. def news coming now .. They have a buyer for sure ..

Morri thank you , i will be holding now .. this is not good for my ticker ..lol

Woh .. the re rate has commenced . after 1 year for me .. I told all last week this will be above 1 p before results confirm historical data that Rock have the a huge supply the biggest to feed the entire EEC with critical minerals ..

RIGHT guys back in at 7,70 p q 160.681 payed £12.379 .. happy days .. this has 10 p written all over it today ..